Achieving Hybrid Monovision By Paring Monofocal And EDOF Lens Technology

April 20, 2022 updated by: Matthias Bolz, Johannes Kepler University of Linz

The Implantation Of Monofocal And Premium IOL Models - A Registry Study At The Kepler University Hospital

Modern day cataract surgery isn't just a rehabilitative procedure anymore but rather aims at improving a patient's quality of life by reducing the need for spectacles in everyday life to a minimum. One way of achieving this goal is by using different lens technologies, such as a monofocal lens paired a lens with EDOF technology, as EDOF lenses provide an enhanced depth of focus by creating a single elongated focal point. As this "mix-and-match" is well established, the aim of this study is to compare the monofocal lens cohort to the EDOF lens cohort and evaluate visual acuity and patient satisfaction.

Study Overview

Study Type

Observational

Enrollment (Actual)

29

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linz, Austria, 4020
        • Johannes Kepler University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 99 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

male and female patients with senile cataract undergoing surgery

Description

Inclusion Criteria:

  • Patient age between 21-99 years
  • signed consent form
  • senile cataract LOCS III grading
  • Cataract surgery with monofocal or premium lens implantation

Exclusion Criteria:

  • missing signed consent form
  • macular pathologies
  • corneal pathologies
  • irregular astigmatism
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
EDOF
Eye after EDOF lens Implantation
A EDOF lens is implanted in the dominant eye
Monofocal
Eye after Monofocal lens Implantation
A monofocal lens is implanted in the non dominant eye.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
uncorrected distance visual acuity
Time Frame: 24 months
Percentage of patients with uncorrected distance visual acuity of logMAR >0.1
24 months
uncorrected intermediate distance visual acuity
Time Frame: 24 months
Percentage of patients with uncorrected intermediate distance visual acuity of logMAR >0.2
24 months
uncorrected near visual acuity
Time Frame: 24 months
Percentage of patients with uncorrected near visual acuity of logMAR >0.2
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dysphotopsia
Time Frame: 24 months
Quality of Vision questionnaire
24 months
PRISQ-Questionnaire
Time Frame: 24 months
questionnaire rating spectacle independency
24 months
Patient Satisfaction
Time Frame: 24 months
Catquest 9-SF-Questionnaire
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 10, 2019

Primary Completion (ACTUAL)

May 12, 2021

Study Completion (ACTUAL)

May 12, 2021

Study Registration Dates

First Submitted

April 20, 2022

First Submitted That Met QC Criteria

April 20, 2022

First Posted (ACTUAL)

April 26, 2022

Study Record Updates

Last Update Posted (ACTUAL)

April 26, 2022

Last Update Submitted That Met QC Criteria

April 20, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KUK-Ophthalmology-006

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract Senile

Clinical Trials on IOL Implantation:EDOF lens

3
Subscribe